This is the authors' abstract. We don't add key points for this paper.
Staphylococcus aureus biofilms are a significant problem in health care settings, partly due to the presence of a nondividing, antibiotic-tolerant subpopulation. Here we evaluated treatment of S. aureus UAMS-1 biofilms with HT61, a quinoline derivative shown to be effective against nondividingStaphylococcusspp. HT61 was effective at reducing biofilm viability and was associated with increased expression of cell wall stress and division proteins, confirming its potential as a treatment for S. aureus biofilm infections.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Frapwell et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: